skip to main content
Show Results with: Show Results with:

Effects of the Cannabinoid-1 Receptor Antagonist Rimonabant on Satiety Signaling in Overweight People With Schizophrenia: Erratum

Journal of clinical psychopharmacology. Volume 36:Issue 1 (2016) -- Wolters Kluwer

Online access

Searching Remote Databases, Please Wait